United States· US:50090-0887_0797d374-f582-4573-8a17-8d55185be64d
Glyburide and Metformin Hydrochloride
A sulfonylureas product containing glyburide and metformin hydrochloride, registered in United States by A-S Medication Solutions.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Glyburide and Metformin Hydrochloride
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- A10BB
- ATC class
- Sulfonylureas
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 4
- ndc11500900887060 TABLET, FILM COATED in 1 BOTTLE (50090-0887-0)
- ndc11500900887130 TABLET, FILM COATED in 1 BOTTLE (50090-0887-1)
- ndc115009008872180 TABLET, FILM COATED in 1 BOTTLE (50090-0887-2)
- ndc11500900887390 TABLET, FILM COATED in 1 BOTTLE (50090-0887-3)
Regulatory notes
Same class
Other records under A10BB
Sulfonylureas, as other registers publish it.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HClHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United StatesGlipizide and Metformin HydrochlorideZydus Pharmaceuticals USA Inc.
- United Statesglyburide and metformin hydrochlorideZydus Lifesciences Limited
- United Statesglyburide and metformin hydrochlorideZydus Lifesciences Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0bab9b4-e20e-47ee-aa86-74b0c2621222 GET /v1/drugs/c0bab9b4-e20e-47ee-aa86-74b0c2621222?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "SX6K58TVWC",
"rxcui": "4815",
"inchikey": "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
"display_name": "GLYBURIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"2239742b-74e1-4bc2-b5a8-15c4758d6f7b": {
"match": "brand_token",
"title": "GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.]",
"spl_version": "6",
"published_date": "2026-05-22"
}
},
"productid": "50090-0887_0797d374-f582-4573-8a17-8d55185be64d",
"productndc": "50090-0887",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "077870",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "1.25MG;250MG",
"product_no": "001",
"approval_date": "Nov 14, 2007"
},
{
"rs": true,
"rld": false,
"te_code": "AB",
"strength": "2.5MG;500MG",
"product_no": "002",
"approval_date": "Nov 14, 2007"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "5MG;500MG",
"product_no": "003",
"approval_date": "Nov 14, 2007"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
"proprietary_name": "Glyburide and Metformin Hydrochloride",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA077870",
"marketing_category": "ANDA",
"nonproprietary_name": "Glyburide and Metformin Hydrochloride",
"start_marketing_date": "20071114",
"active_numerator_strength": "2.5; 500"
}See everything about glyburide and metformin hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.